Paris Times
Liberté, Égalité, Fraternité
Tuesday, Oct 06, 2026
Paris Times
vaccine
Sanofi Wins European Approval for New Respiratory Syncytial Virus Vaccine
Sanofi received European regulatory authorisation for a next-generation respiratory syncytial virus vaccine designed to reduce the burden of seasonal respiratory illness.
Sanofi Weighs Industrial Restructuring to Prioritise Next-Generation Vaccines
French pharmaceutical group Sanofi is discussing changes to its domestic manufacturing footprint as it redirects investment toward advanced immunology and new vaccine technologies.
Sanofi Plans Transfer of 20 Mature Medicines and Three Plants to Cheplapharm
Sanofi intends to transfer a portfolio of established medicines and manufacturing sites to Cheplapharm in exchange for a 26.4% equity stake, allowing the French pharmaceutical group to maintain its focus on newer medicines and vaccines. ...
Sanofi Expands Vaccine Manufacturing Capacity in France
Sanofi plans further investment in vaccine production facilities in the Auvergne-Rhône-Alpes region as France seeks to strengthen domestic pharmaceutical manufacturing capacity.
France Reports Stable Seasonal Vaccine Supplies Ahead of Autumn Campaign
The pharmaceutical industry says distribution networks hold sufficient influenza vaccine stocks for the forthcoming autumn vaccination campaign.
Sanofi Plans €1.5 Billion mRNA Vaccine Plant in France
Sanofi announced a €1.5 billion investment in a new messenger RNA vaccine manufacturing facility in the Auvergne-Rhône-Alpes region, supported by the French government as part of efforts to strengthen domestic medical supply capacity.
Sanofi Announces Major Biotechnology Investment in Lyon
Sanofi is modernizing research and manufacturing facilities in the Auvergne-Rhone-Alpes region with state support, aiming to expand domestic vaccine capacity and strengthen European preparedness for future disease outbreaks.
Sanofi Forms Joint Venture to Develop Respiratory Syncytial Virus Vaccine
French pharmaceutical group Sanofi agreed to co-develop and manufacture a respiratory syncytial virus vaccine with a United States biotechnology company as competition grows in preventive respiratory treatments.
Sanofi Invests €1 Billion in French Biopharma and Vaccine Manufacturing
Sanofi announced a €1 billion program to expand production and research facilities in France, including work on synthetic biology, monoclonal antibodies and next-generation mRNA vaccines.
Sanofi Reports Positive Late-Stage Results for New Respiratory Vaccine
French pharmaceutical company Sanofi has reported promising phase-three trial results for a next-generation respiratory vaccine, strengthening the prospects for a new product ahead of the winter respiratory infection season.
Sanofi Wins European Approval for MenQuadfi Meningococcal Vaccine for Infants
Sanofi has received European Union approval for MenQuadfi, a meningococcal vaccine for infants from six weeks of age, expanding protection against invasive meningococcal disease.
Sanofi Invests Eight Hundred Million Euros in New Vaccine Manufacturing Facility in France
Sanofi will build an advanced messenger RNA vaccine plant in the Auvergne-Rhone-Alpes region as France seeks to strengthen domestic pharmaceutical production capacity for future health emergencies.
Sanofi Expands Vaccine Manufacturing Capacity Near Lyon
Sanofi completed a major expansion of its vaccine production facility near Lyon, increasing European manufacturing capacity for seasonal influenza and future pandemic response.
Sanofi Reports Strong Malaria Vaccine Trial Results in West Africa
French pharmaceutical company Sanofi has reported Phase Two trial results showing eighty percent efficacy for a new malaria vaccine among children in West Africa and plans to accelerate regulatory submissions.
Sanofi Reports Positive Results for Next-Generation Respiratory Vaccine
French pharmaceutical company Sanofi has announced successful late-stage clinical trial results for a messenger RNA vaccine targeting multiple seasonal respiratory viruses, with European approval expected later this year.
Sanofi Wins Approval for New RSV Vaccine for Older Adults
The European Medicines Agency authorized Sanofi’s latest respiratory syncytial virus vaccine, providing the company with a new growth opportunity while strengthening public health preparedness ahead of winter.
Sanofi Reports Positive Late-Stage Results for New mRNA Respiratory Vaccine
Researchers at Sanofi's Lyon facility have announced successful late-stage clinical trial outcomes for a multivalent respiratory vaccine, strengthening the company's position in advanced vaccine development.
BASF? Wait not France—Valneva Advances Commercialization Plans Ahead of Lyon Shareholder Meeting
Vaccine maker Valneva has released documentation for its annual meeting as shareholders prepare to review investment plans supporting vaccine distribution and future clinical development.
Sanofi Expands Vaccine Production Capacity Across Europe
The pharmaceutical company is increasing manufacturing investment to strengthen medicine supply security and reduce European dependence on imported active ingredients.
Sanofi Expands Biopharmaceutical Manufacturing Capacity in Lyon
Sanofi committed hundreds of millions of euros to enlarge vaccine and biologics production facilities in the Lyon region, strengthening domestic manufacturing capacity and pharmaceutical supply chains.
Sanofi Invests More Than €300 Million to Expand mRNA Vaccine Production in Lyon
The French pharmaceutical company is scaling up biotechnology manufacturing capacity to strengthen domestic supply chains for advanced vaccines and oncology treatments.
World Health Organization Issues High Alert on Mutating Avian Influenza
Global health monitors have detected human-to-human transmission clusters of a highly pathogenic H5N1 strain in Southeast Asia, triggering emergency vaccine production protocols.
Listen
Kennedy’s Quiet War on Antidepressants Sparks Alarm Across America’s Medical Establishment
Reports that U.S. health officials explored curbs on widely used SSRI medications have ignited a fierce national battle over psychiatry, regulation and the future of mental health treatment.
Listen
United States under President Donald Trump completes withdrawal from the World Health Organization: health sovereignty versus global outbreak early-warning access
Secretary of State Marco Rubio and Health Secretary Robert F. Kennedy Jr. framed the exit as a COVID-era accountability move while U.S. participation in WHO committees and information channels ends.
Listen
Load More
Playlist
Hide
0:00
0:00
Open
Paris Times
Liberté, Égalité, Fraternité
0:00
0:00
Close
TSA Unveils Major Airport-Security Overhaul as It Drops Gold+ Privatization Plan
German Broadcaster Goes Dark to Warn AfD Could End Its Saxony-Anhalt Service
Prime Minister Andy Burnham to Give Ukraine Classified Storm Shadow Blueprints for Domestic Missile Production
Brighton Thrash Aston Villa in Four-Goal Opening Half as Manchester City Trail Bournemouth
Ukraine's Ousted Defence Minister Calls for Wartime Presidential Election
Cristiano Ronaldo and Georgina Rodríguez Sign Prenup Protecting Their Separate Fortunes
Thieves Steal Antonello da Messina Renaissance Masterpieces From Sicilian Museum
Google Launches Pixel 11 With Gemini AI at the Center of Its Hardware Strategy
France's Constitutional Council Blocks Social Media Ban for Children Under 15
Liechtenstein Changes Royal Succession Rules to Allow Women to Inherit the Throne
Couples Embrace ‘Sleep Divorce’ to Protect Rest and Reduce Tension
Success: Nvidia Turned Gaming Chips Into the Engine of the AI Boom
AI’s Next Bottleneck Is Power, Not Just Nvidia Chips
Meta Raises AI Spending Target to as Much as $145bn Despite Pressure Over Returns
Danube Drought Exposes Nazi Wrecks and Pushes Central Europe’s Power System to the Brink
Joe Biden’s Cancer Has Spread Beyond His Bones, Hunter Biden Says
Why 2027 Could Be a Strong Year for Stocks—and Why the Forecast Is Fragile
Why Markets May Look Quiet in August After Big Tech Earnings
Trump-Era Policy Shifts Test the Boundaries of U.S. Institutions
UK Drought Cuts Harvests and Raises Food-Security Fears
Ukraine Tells Senate Republicans Its Drone War Offers a Blueprint for America
Weight-Loss Drug Boom Tests the Limits of Prescription Advertising Rules
Scotland’s ‘Cock of the North’ Woodland Is Being Felled After Wind Damage
Senate Scrutinises AI-Driven Personalised Pricing
Spain Seeks Mainland Transfers for 1,100 Children Stranded in Ceuta
Spain and Morocco Trade Blame After 72,000 Migrants Enter Ceuta
AI Is Remaking the US Economy, From GDP Growth to iPhone Prices
Reform UK Wants the Royal Navy to Return Channel Boats to France
Europe’s Heat and Drought Are Now Disrupting Power, Shipping and Tourism
World War II munitions discovered after wildfires in southern France
Record-Low Danube Forces Nuclear Cuts and Emergency Power Curbs
Danube Drought Forces Hungary’s Paks Nuclear Plant Into Full Shutdown
Ceuta Death Toll Rises as Spain and Europe Clash Over Border Response
Valued at $109 Million: F-35B Fighter Jet Crashes in Southern California
Record-Low Danube Exposes Probable Mammoth Remains in Bulgaria
US Says It Has Carried Out Heavy Strikes on Iran After Attempted Attacks on Its Forces
Over 24 Hours in the Air: Qantas Airbus Completes Record-Breaking Test Flight
Massive Wildfires Ravage Southern Europe: Fatalities in Greece and Evacuations Across France, Spain, and Turkey
Trump says Israel ‘would not survive’ without US
France Evacuates Atlantic Coast Resorts as Wildfire Risk Rises Again
Nvidia Reportedly Takes Vast Texas Data-Centre Lease to Underwrite AI Expansion
FIFA’s Private-Investment Plan for World Cup Rights Draws European Revolt
Fresh Heatwave Threatens to Rekindle France’s Historic Wildfire Crisis
Following OpenAI's Cyberattack: 'Most Companies Still Do Not Understand What Is Coming'
War, Power and the Rising Price of Political Decisions
OpenAI Sued After ChatGPT Allegedly Discouraged Emergency Care Before Near-Fatal Embolism
Miliband Sets Climate and International Law at Centre of UK Diplomacy
Czech Central Bank Governor Rejects Early Euro Entry and Rate-Cut Pressure
Trump Readies New Tariffs as Temporary Global Levy Nears Expiry
EU Imposes Record €550 Million Digital Services Fine on AliExpress
0:00
/
0:00
×
